Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 1 - Issue 1 - Sept/Oct 2004

Feature

Original Research
Excimer Laser-Assisted Angioplasty in Severe Infrapopliteal Disease and CLI: The CIS LACI Equivalent Experience
09/05/2008

David E. Allie, MD; Chris J. Hebert, RT, RCIS; Craig M. Walker, MD

 

Cardiovascular Institute of the South/Lafayette, Lafayette, Louisiana

David E. Allie, MD; Chris J. Hebert, ...
The TransAtlantic Inter-Societal Consensus committee and document on the management of peripheral arterial occlusive disease have recently attempted to unify and clarify CLI with the following recommendations.
The TransAtlantic Inter-Societal Consensus committee and document on the management of peripheral arterial occlusive disease have recently attempted to unify and clarify CLI with the following recommendations.
The TransAtlantic Inter-Societal...
09/05/2008
Vascular Disease Management
Case Report
Percutaneous Mechanical Thrombectomy Combined With Thrombolysis for the Treatment of Deep Venous Thrombosis
09/05/2008

Lin, MD; Bush, MD

Lin, MD; Bush, MD
Multiple sequelae may occur after deep venous thrombosis (DVT), including acute limb symptoms such as swelling and pain, valvular damage and reflux leading to chronic symptoms, and, the most serious, pulmonary embolism and death.
Multiple sequelae may occur after deep venous thrombosis (DVT), including acute limb symptoms such as swelling and pain, valvular damage and reflux leading to chronic symptoms, and, the most serious, pulmonary embolism and death.
Multiple sequelae may occur...
09/05/2008
Vascular Disease Management
Case Report
Intracranial Middle Cerebral Artery Percutaneous Intervention Using a Drug-Eluting Stent
09/05/2008
Intracranial angioplasty and stenting are increasingly being used to treat patients with recurrent cerebral ischemia due to intracranial atherosclerosis, which is a cause of 8-10% of all ischemic strokes.
Intracranial angioplasty and stenting are increasingly being used to treat patients with recurrent cerebral ischemia due to intracranial atherosclerosis, which is a cause of 8-10% of all ischemic strokes.
Intracranial angioplasty and...
09/05/2008
Vascular Disease Management
Original Research
Bivalirudin in Peripheral Vascular Interventions: A Single Center Experience
09/05/2008

Nicolas W Shammas; Jon H Lemke; Eric J. Dippel; Dawn E. McKinney; Vickie S, Takes; Monica Youngblut; Melodee Harris

Nicolas W Shammas; Jon H Lemke; Eric ...
Unfractionated heparin is the current antithrombotic agent utilized during peripheral angioplasty procedures.
Unfractionated heparin is the current antithrombotic agent utilized during peripheral angioplasty procedures.
Unfractionated heparin is the...
09/05/2008
Vascular Disease Management
Update
Update: Bivalirudin in Peripheral Vascular Intervention
09/05/2008

Nicolas W Shammas, MD

Nicolas W Shammas, MD
Despite the sharp rise in peripheral vascular interventions (PVI), complication rates have continued to be significant and, in fact, limb loss has trended upwards.
Despite the sharp rise in peripheral vascular interventions (PVI), complication rates have continued to be significant and, in fact, limb loss has trended upwards.
Despite the sharp rise in...
09/05/2008
Vascular Disease Management
Case Report
Multidetector Computerized Tomography for the Evaluation of Cerebrovascular Disease: A Case Study
09/05/2008

C. Goldman, MD
Ochsner Health, New Orleans, Louisiana

C. Goldman, MD Ochsner Health, New Or...
A 59-year-old hypertensive, diabetic, white male ex-smoker with a history of CABG in 1994. In 1997, he underwent insertion of a pacemaker for bradycardia. In 1999, he was diagnosed with squamous cell laryngeal cancer by biopsy.
A 59-year-old hypertensive, diabetic, white male ex-smoker with a history of CABG in 1994. In 1997, he underwent insertion of a pacemaker for bradycardia. In 1999, he was diagnosed with squamous cell laryngeal cancer by biopsy.
A 59-year-old hypertensive,...
09/05/2008
Vascular Disease Management

Insights

Interview
Percutaneous Intraspinal Navigation (PIN)
09/05/2008

Phillip Purdy, MD
University of Texas Southwestern Medical Center, Dallas, Texas

Phillip Purdy, MD University of Texas...
Just as we’ve been using the arteries as a conduit to navigate the vascular system for a long time, we also believe it may be possible to use the space surrounding the brain and spinal cord to navigate in and around the brain and spinal cord.
Just as we’ve been using the arteries as a conduit to navigate the vascular system for a long time, we also believe it may be possible to use the space surrounding the brain and spinal cord to navigate in and around the brain and spinal cord.
Just as we’ve been using the...
09/05/2008
Vascular Disease Management
Interview
Percutaneous Revascularization for SFA/Popliteal Arterial Disease: When and Why
09/05/2008

David E. Allie, MD1; Nicolas W. Shammas, MS, MD2; Frank J. Criado, MD3; Michael R. Jaff, DO4; Gary M. Ansel, MD5; Sandeep Khosla, MD6

 

1Cardiovascular Institute of the South/Lafayette, Lafayette, Louisiana; 2Genesis Heart Institute, Cardiovascular Medicine, PC, Davenport, Iowa; 3Union Memorial Hospital/MedStar Health Baltimore, Maryland; 4Vascular Ultrasound Core Laboratory, Massachusetts General Hospital, Boston, Massachusetts; 5Mid Ohio Cardiology Consultants, Columbus, Ohio; 6Endovascular Therapeutics Mount Sinai Hospital, Chicago, Illinois

David E. Allie, MD1; Nicolas W. Shamm...
In our experience, 40-50% of CLI patients will have SFA/popliteal involved and 30-40% in LACI trial.
In our experience, 40-50% of CLI patients will have SFA/popliteal involved and 30-40% in LACI trial.
In our experience, 40-50% of CLI...
09/05/2008
Vascular Disease Management

Column

Editor's Corner
Welcome to Vascular Disease Management
09/05/2008

Frank J. Criado, MD

 

Editor-in-Chief 

 

Director, Center for Vascular Intervention Chief, Division of Vascular Surgery Union Memorial Hospital/MedStar Health Baltimore, Maryland

Frank J. Criado, MD   Editor-in-Chi...
It is with a sense of pride and excitement that I set out to write the first Editor’s Letter for the inaugural issue of Vascular Disease Management (VDM).
It is with a sense of pride and excitement that I set out to write the first Editor’s Letter for the inaugural issue of Vascular Disease Management (VDM).
It is with a sense of pride and...
09/05/2008
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

Sleep and CVD
Study of Sleep in Women Shows Delaying Bedtime by Just 90 Minutes Each Night Damages Endothelial Cells
08/06/2024
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of...
08/06/2024
Cath Lab Digest
Peripheral Interventions
VentureMed Completes Enrollment of the FLEX Vessel Prep System FLEX First AV Registry For The Treatment of Arteriovenous (AV) Access Management
07/30/2024
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has...
07/30/2024
Cath Lab Digest
Peripheral Interventions
Transit Scientific’s Novel XO Cath Microcatheter Breaks New Ground in Transradial Embolic Delivery Procedure
07/30/2024
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a...
07/30/2024
Cath Lab Digest
Carotid Artery Revascularization
Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
07/30/2024
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery...
07/30/2024
Cath Lab Digest
Health Care Needs
JACC: Almost Half of U.S. Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality
07/29/2024
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S....
07/29/2024
Cath Lab Digest
Renal Denervation
First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension With Ultrasound Renal Denervation
07/25/2024
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on...
07/25/2024
Cath Lab Digest
Ischemic Stroke
Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke
07/24/2024
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all...
07/24/2024
Cath Lab Digest
LINC
News
HMP Global’s Leipzig Interventional Course (LINC) Announces 20th Anniversary Congress in January 2025
07/22/2024
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier...
07/22/2024
Vascular Disease Management
News
Life Seal Vascular Inc. Awarded Prestigious NSF SBIR Grant to Advance Innovative Endovascular Aortic Aneurysm Sac Management Technology
07/17/2024
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF...
07/17/2024
Vascular Disease Management
Ischemic Stroke
Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke
07/17/2024
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the...
07/17/2024
Cath Lab Digest

Advertisement

Advertisement

September 2004 Volume 1 Issue 1

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement